Bio-Vent Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Bio-Vent General Information
Description
Developer of an anti-influenza drug designed to target the viruses responsible for influenza. The company's drug is based on aptamers which are oligonucleotide or peptide molecules that bind to a specific target molecule, enabling healthcare providers to treat their patients and improve their lives.
Contact Information
Website
www.bio-vent.comCorporate Office
- Tzomet Abba Hillel
- Yakhin Park
- Ashkelon 7284
- Israel
Corporate Office
- Tzomet Abba Hillel
- Yakhin Park
- Ashkelon 7284
- Israel
Bio-Vent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Aug-2017 | Completed | Out of Business | |||
| 1. Early Stage VC | 01-Oct-2014 | Completed | Startup |
Bio-Vent FAQs
-
When was Bio-Vent founded?
Bio-Vent was founded in 2006.
-
Where is Bio-Vent headquartered?
Bio-Vent is headquartered in Ashkelon, Israel.
-
What industry is Bio-Vent in?
Bio-Vent’s primary industry is Drug Discovery.
-
Is Bio-Vent a private or public company?
Bio-Vent is a Private company.
-
What is Bio-Vent’s current revenue?
The current revenue for Bio-Vent is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process